Rayence Balance Sheet Health
Financial Health criteria checks 6/6
Rayence has a total shareholder equity of ₩240.8B and total debt of ₩2.1B, which brings its debt-to-equity ratio to 0.9%. Its total assets and total liabilities are ₩277.5B and ₩36.7B respectively. Rayence's EBIT is ₩19.7B making its interest coverage ratio -8. It has cash and short-term investments of ₩148.7B.
Key information
0.9%
Debt to equity ratio
₩2.06b
Debt
| Interest coverage ratio | -8x |
| Cash | ₩148.65b |
| Equity | ₩240.80b |
| Total liabilities | ₩36.69b |
| Total assets | ₩277.49b |
Recent financial health updates
We Think Rayence (KOSDAQ:228850) Can Stay On Top Of Its Debt
Mar 31
Rayence (KOSDAQ:228850) Seems To Use Debt Quite Sensibly
Dec 01
Recent updates
We Think Rayence (KOSDAQ:228850) Can Stay On Top Of Its Debt
Mar 31Rayence Co., Ltd. (KOSDAQ:228850) Is Up But Financials Look Inconsistent: Which Way Is The Stock Headed?
Mar 05Will Rayence (KOSDAQ:228850) Multiply In Value Going Forward?
Feb 17Are Rayence's (KOSDAQ:228850) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Feb 02Rayence's(KOSDAQ:228850) Share Price Is Down 44% Over The Past Three Years.
Jan 18Should Rayence Co., Ltd. (KOSDAQ:228850) Be Part Of Your Dividend Portfolio?
Jan 06Income Investors Should Know That Rayence Co., Ltd. (KOSDAQ:228850) Goes Ex-Dividend Soon
Dec 25At ₩11,100, Is It Time To Put Rayence Co., Ltd. (KOSDAQ:228850) On Your Watch List?
Dec 14Rayence (KOSDAQ:228850) Seems To Use Debt Quite Sensibly
Dec 01A Look At The Intrinsic Value Of Rayence Co., Ltd. (KOSDAQ:228850)
Nov 18Financial Position Analysis
Short Term Liabilities: A228850's short term assets (₩231.8B) exceed its short term liabilities (₩30.0B).
Long Term Liabilities: A228850's short term assets (₩231.8B) exceed its long term liabilities (₩6.6B).
Debt to Equity History and Analysis
Debt Level: A228850 has more cash than its total debt.
Reducing Debt: A228850's debt to equity ratio has reduced from 0.9% to 0.9% over the past 5 years.
Debt Coverage: A228850's debt is well covered by operating cash flow (1252.8%).
Interest Coverage: A228850 earns more interest than it pays, so coverage of interest payments is not a concern.